High-impact NHP screening Target institutions and biorepositories conducting nonhuman primate research or colony management to leverage Intuitive Biosciences’ turnkey immunoassay platform for routine SPF screening, antibody titer monitoring, and infectious disease surveillance.

Turnkey OEM Opportunity Position the company’s turnkey system or OEM consumables and software as scalable solutions for large labs and contract research organizations seeking fast deployment, standardized assays, and integrated reporting for infectious disease and vaccine monitoring.

SMB Growth Potential Capitalize on the small team size by targeting mid-size biotech and academic core facilities that need cost-efficient, easy-to-use platforms with strong support and rapid onboarding to expandcustomer base beyond ultra-large incumbents.

Digital Engagement Leverage existing tech stack signals (HubSpot, web optimization, analytics) to nurture leads, promote new product launches, and drive direct conversions from email lists and webinars, highlighting updates in tuberculosis and SARS-CoV-2 screening capabilities.

Funding and Partnerships Align outreach with potential buyers who are funded or pursuing grants in infectious disease diagnostics, vaccine research, and nonhuman primate health monitoring, offering collaboration opportunities, pilot programs, and co-development of assays.